The global microbial identification market size was valued at USD 4.19 billion in 2024 and is projected to reach USD 8.18 billion by 2030, growing at a CAGR of 11.91% between 2025 and 2030. The rising prevalence of infectious diseases, coupled with continuous technological advancements, is expected to be a key driver of market growth.

Growing R&D activities, along with increasing government investments in biotechnology and life sciences, are expected to accelerate market expansion. Additionally, rising concerns about food safety and the need for environmental monitoring are anticipated to further drive market growth from 2025 to 2030.

The microbial identification industry is in a high-growth stage, with the pace of development accelerating. The global burden of infectious diseases, along with the emergence of new pathogens, highlights the need for accurate and rapid identification methods to ensure timely treatment.

Mergers and acquisitions (M&A) remain a defining characteristic of the industry, as leading players seek to expand their product portfolios, strengthen market positions, and leverage the growing importance of microbiology. For instance, in June 2022, bioMérieux completed the acquisition of Specific Diagnostics for about USD 416.8 million, representing 3.2% of the French diagnostic company’s market value.

Stringent regulations on pharmaceutical, medical device, and food product safety have further accelerated the adoption of microbial identification solutions. Government initiatives aimed at controlling the spread of infectious diseases also contribute significantly to the industry’s growth.

Technological advancements, rising demand for rapid diagnostics, and expanding applications across pharmaceuticals, food safety, and environmental monitoring are creating new innovation and growth opportunities. Regional expansion, particularly across emerging economies with improving healthcare infrastructure and increasing R&D investments, is also fueling market acceleration.

Key Market Trends & Insights

• Regional Insights: Europe automotive radar market dominated with a share of 36.02% in 2023, while North America led the microbial identification market with a revenue share of 38.38% in 2024. The U.S. microbial identification market is projected to grow significantly during the forecast period.

• Product & Services: The consumables segment accounted for the largest market share at 36.60% in 2024.

• Technology: The PCR segment held the largest share at 36.69% in 2024.

• Methods: Genotypic methods represented the largest market share of 42.19% in 2024 and are anticipated to grow at the highest CAGR from 2025 to 2030.

Order a free sample PDF of the Microbial Identification Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 4.19 Billion

• 2030 Projected Market Size: USD 8.18 Billion

• CAGR (2025–2030): 11.91%

• Largest Market (2024): North America

• Fastest Growing Market: Asia Pacific

Key Microbial Identification Company Insights

Leading companies in the microbial identification market are actively pursuing expansion activities, partnerships, and product portfolio enhancements to strengthen their competitive position and extend their global reach.

Key Companies Include:

• bioMérieux SA
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Danaher Corporation
• Qiagen N.V.
• Charles River Laboratories
• Wickham Micro Limited
• VWR International LLC. (Avantor Inc.)
• Shimadzu Corporation
• Merck KGaA
• Eurofins Scientific SE
• Biolog Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The microbial identification market is experiencing rapid growth, driven by increasing infectious disease prevalence, regulatory compliance needs, and technological innovation. With North America leading in current market share and Asia Pacific emerging as the fastest-growing region, opportunities are widespread across both developed and developing economies. Strategic M&A activity, government support, and expanding applications in pharmaceuticals, food safety, and environmental monitoring are expected to sustain momentum, making microbial identification a critical industry for the future of healthcare and global safety.

browse our blog: https://globalindustryherald.com/